The FertiGen® Story
In early 2015, a decision was made to create the Center for Advanced Genetics (CAG), a small private reproductive endocrinology practice between Los Angeles & San Diego.
CAG grew quickly. Soon this boutique clinic became the first IVF unit in the United States to study ovarian treatment with platelet derived growth factors.
Although initially skeptical, Dr. Sills revised his view on platelet cytokines as data from the fresh plasma clinical trial showed that this approach deserved more attention.
The FertiGen marque was established first to set safe standards for this technology, and a corresponding provisional U.S. Patent followed next.
Hormonal profile changes measured after FertiGen can reveal boosted reproductive capacity, where ovaries once considered dormant are reawakened.